Steven Cohen Novavax Inc Transaction History
Point72 Asset Management, L.P.
- $51 Billion
- Q3 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Novavax Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 96,917 shares of NVAX stock, worth $675,511. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,917
Previous 175,000
44.62%
Holding current value
$675,511
Previous $1.1 Million
23.77%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NVAX
# of Institutions
311Shares Held
95.7MCall Options Held
5.7MPut Options Held
9.06M-
Vanguard Group Inc Valley Forge, PA15.2MShares$106 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$82.6 Million0.0% of portfolio
-
Shah Capital Management11.8MShares$82.3 Million45.37% of portfolio
-
State Street Corp Boston, MA7.2MShares$50.2 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.27MShares$29.8 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $545M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...